1. Home
  2. ARCT vs NPCT Comparison

ARCT vs NPCT Comparison

Compare ARCT & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • NPCT
  • Stock Information
  • Founded
  • ARCT 2013
  • NPCT 2020
  • Country
  • ARCT United States
  • NPCT United States
  • Employees
  • ARCT N/A
  • NPCT N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • NPCT Investment Managers
  • Sector
  • ARCT Health Care
  • NPCT Finance
  • Exchange
  • ARCT Nasdaq
  • NPCT Nasdaq
  • Market Cap
  • ARCT 320.8M
  • NPCT 314.9M
  • IPO Year
  • ARCT N/A
  • NPCT N/A
  • Fundamental
  • Price
  • ARCT $20.68
  • NPCT $10.86
  • Analyst Decision
  • ARCT Strong Buy
  • NPCT
  • Analyst Count
  • ARCT 9
  • NPCT 0
  • Target Price
  • ARCT $50.88
  • NPCT N/A
  • AVG Volume (30 Days)
  • ARCT 826.4K
  • NPCT 107.1K
  • Earning Date
  • ARCT 11-06-2025
  • NPCT 01-01-0001
  • Dividend Yield
  • ARCT N/A
  • NPCT 9.82%
  • EPS Growth
  • ARCT N/A
  • NPCT N/A
  • EPS
  • ARCT N/A
  • NPCT N/A
  • Revenue
  • ARCT $122,122,000.00
  • NPCT N/A
  • Revenue This Year
  • ARCT N/A
  • NPCT N/A
  • Revenue Next Year
  • ARCT $28.92
  • NPCT N/A
  • P/E Ratio
  • ARCT N/A
  • NPCT N/A
  • Revenue Growth
  • ARCT N/A
  • NPCT N/A
  • 52 Week Low
  • ARCT $8.04
  • NPCT $8.58
  • 52 Week High
  • ARCT $24.13
  • NPCT $10.63
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.66
  • NPCT 45.88
  • Support Level
  • ARCT $20.08
  • NPCT $10.82
  • Resistance Level
  • ARCT $23.60
  • NPCT $10.98
  • Average True Range (ATR)
  • ARCT 1.71
  • NPCT 0.13
  • MACD
  • ARCT -0.03
  • NPCT -0.00
  • Stochastic Oscillator
  • ARCT 42.79
  • NPCT 50.82

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest

Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.

Share on Social Networks: